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CBackground: Response burden is often defined as the effort required
by the patient to answer a questionnaire. A factor that has been pro-
posed to affect the response burden is questionnaire length, and this
burden is manifested in, for example, response rate. Even though re-
sponse burden is frequently mentioned as a reason for abridging ques-
tionnaires, evidence to support the notion that shorter instruments are
preferable is limited. Objectives: This study aimed to accumulate, an-
lyze, and discuss evidence regarding the association between re-
ponse burden, as measured by response rate, and questionnaire
ength. Methods: A systematic literature review and meta-analysis of
tudies reporting response rates in relation to questionnaire length
as performed. A Cochran-Mantel-Haenszel test stratified by study
sing the Breslow-Day testwas undertaken to investigate homogeneity
f the odds ratios.Results: Thirty-two reportswere identified, ofwhich
0 were eligible for inclusion in the meta-analysis. Three studies used O
oom
al So
doi:10.1016/j.jval.2011.06.003atient input as main outcome when evaluating response burden. In
he meta-analysis, a general association between response rate and
uestionnaire lengthwas found (P 0.0001). Response rateswere lower
for longer questionnaires, but because the P value for test of homoge-
neity was P  0.03, this association should be interpreted with caution
ecause it is impossible to separate the impact of content from length
f the questionnaires. Conclusion: Given the inherently problematic
ature of comparing questionnaires of various lengths, it is preferable
o base decisions on use of instruments on the content rather than the
ength per se.
eywords: content validity, meta-analysis, patient-reported outcomes,
uestionnaire length, response rates.
opyright © 2011, International Society for Pharmacoeconomics and
utcomes Research (ISPOR). Published by Elsevier Inc.Introduction
There is no consensus on how to define response burden. Factors
such as questionnaire length, density of sampling, cognitive load
required completing the survey, and layout and interface of the
reporting format have been suggested to affect the strain on the
patient [1]. Other similar concepts are respondent burden, re-
sponse fatigue, and subject burden. Increased response burden
has been proposed to result in lower response rates, reduced com-
pletion, and reduced data quality [2,3]. Response burden may be
particularly problematic in demographic groups such as the se-
verely ill, older individuals, and children [4]. A strong focus has
been on questionnaire length, and, consequently, potential re-
sponse burden is frequently a rationale for reducing the number of
items in existing questionnaires (e.g., the short version of the
Short-Form Health Survey [SF-36], SF-12 [5]) and is also driving
development of questionnaireswith aminimumof items. Lengthy
questionnaires have beenmentioned as a general obstacle in clin-
ical practice [6] and used as an argument for limiting the overall
number of administrations of an instrument. Some studies have
even proposed that a single item is preferable to reduce response
burden [7]. Techniques such as item response theory, computer
adaptive testing, skip sequencing, and item banking may offer
* Address correspondence to: Sindre Rolstad, AstraZeneca R&D, R
E-mail: sindre.rolstad@astrazeneca.com.
1098-3015/$36.00 – see front matter Copyright © 2011, Internation
Published by Elsevier Inc.reduced response burden because items may be more tailored to
meet patients’ response patterns compared to traditional paper
and pencil forms. Even though response burden is frequently
mentioned as a reason for reducing the number of items and total
administration time, there may not be strong empirical evidence
to support the notion that comparatively shorter instruments are
preferable. Increased regulatory demands on patient-reported
outcomes (PROs) [1] (e.g., acuity of recall accuracy, content valid-
ity, and preference for the use of an electronic reporting format)
may have resulted in increased sampling density (frequency of
measurement). Thus, there is an augmented need to understand
whether there is an association between questionnaire length and
response burden.
In this review, current evidence concerning response burden in
relation to questionnaire length is compiled and analyzed and
unresolved issues are exposed, highlighting research priorities for
the future.
Methods
Original studies evaluating the relationship between question-
naire length and response rate were identified by systematic
searches of PubMed and EMBASE. Studies fulfilling the following
GA252B, Pepparedsleden 1, SE-431 83 Mölndal, Sweden.
ciety for Pharmacoeconomics and Outcomes Research (ISPOR).
1102 V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 1 1 0 1 – 1 1 0 8criteria were eligible for inclusion in the analysis: published in a
peer-reviewed journal, in the English language, including ques-
tionnaires, and on the topic of health/disease/medicine. No limits
were set with regard to date of publication (an article was eligible
if indexed at the day of the last literature search, January 10, 2011).
In addition, a report needed to include a measure indicative of
response burden. All measures of response burden, either direct
(generally by obtaining patient input) or indirect (e.g., by assessing
response rates) were included. Reports were excluded if response
burden was defined as time to complete a questionnaire because
this is not a clear indication of burden, but rather reflects the fact
that longer questionnaires take more time to complete. Evidence
relating to increased burden (e.g., reduced response rates or pa-
tient input) was required for inclusion in the literature review de-
scribed here. In this review, the terms shorter and longer refer to
within-study differences using the individual study authors’ defi-
nitions. Alternatively, when referring to the meta-analysis,
shorter and longer refer to the discrete categories to which the
studies have been assigned.
Statistics
All studies included in the meta-analysis included questionnaires
defined by the authors of that report as shorter and longer. These
definitions of relative length were used to dichotomize the studies
into shorter and longer questionnaires. The difference in response
rates between shorter and longer questionnaires was analyzed
using a Cochran-Mantel-Haenszel test stratified by study [8]. This
is an analysis of the relationship between response rate and length
of questionnaires, controlled for study. The Cochran-Mantel-
Haenszel estimate of the common odds ratio (OR) over all strata is
presented together with the corresponding 95% confidence inter-
val (CI). The Breslow-Day test for homogeneity of the ORs in the
studies is also presented [9]. All statistical analyses were per-
formed using SAS software (version 8.2, SAS Institute, Cary, NC)
and the R computing environment (version 2.12.0, The R Founda-
tion, http://www.r-project.org).
Literature review
The systematic search for studies on the relationship between
Table 1 – Search terms, number of hits, and number of rele
Search terms
Subject/patient/response/respondent/testing/number of items  bur
“Response fatigue”
“Burden of report”
Questionnaire*/survey*/scale*  length  burden
“Questionnaire length”/“survey length”/“scale length”/“number of
items”  response rate
“Questionnaire length”/“survey length”/“scale length”/“number of
items”  compliance
Extensive  questionnaire/survey/scale
Brief*/short*/abridge*  length  questionnaire/survey/scale
Long*  short*/brief*abridge*  questionnaire*/survey*/scale*
“Concise  questionnaire*/survey*/scale*”
“Lengthy  questionnaire*/survey*/scale*”
“Comprehensive  questionnaire*/survey*/scale*”  brief
“Comprehensive  questionnaire*/survey*/scale*”  short*/brief*/abi
“Long*  questionnaire*/survey*/scale*”
Relevant articles retrieved from relevant hits
Total no.
Relevant hits do not include duplicates of previously listed search te
n/a, not applicable.questionnaire length and respondent burden yielded 4861 recordsof potentially relevant studies (Table 1). After screening records
and obtaining copies of the reports considered useful for further
inspection, a total of 21 reports, 2 meta-analyses and 19 seminal
articles were found to match the eligibility criteria. Review of rel-
evant references resulted in the addition of a further 11 seminal
articles. Previous relevant meta-analyses on the relationship be-
tween questionnaire length and respondent burden are discussed
in the following. Seminal articles not included in the previous re-
views were subsequently grouped on the basis of whether a sig-
nificant association between respondent burden, as assessed by
response rates, and questionnaire length was reported. Two stud-
ies reported a significant association, whereas 12 did not. Signifi-
cance was defined using authors’ prespecified criteria; in general,
a P value0.05 was used to determine significance. One exception
was Jenkinson et al. [10], who required a 10% difference in re-
sponse rates to be considered significant. Studies investigating the
effect of questionnaire length on response rates are also depicted
in Table 2. Thereafter, three studies are presented that usedmeth-
ods to obtain information directly frompatients regarding respon-
dent burden. Any measure indicating respondent burden, either
directly or indirectly, is stated, as is any indication of data quality,
if disclosed. The literature review concludes by ameta-analysis of
the potential association between response rates and question-
naire length.
In total, 24 of 25 studies reporting response rates compared the
effect of questionnaire length across groups; one study was ex-
cluded for not reporting response rates [11]. The most commonly
reported indication of questionnaire length was pages. Of the 24
eligible studies, 7 did not report the number of items [12–18],
whereas 4 did not report the number of pages [19–22]. Accordingly,
the number of pages was used as the measure of questionnaire
length in the meta-analysis, resulting in an exclusion of the stud-
ies only reporting the number of items. All of the 20 studies in-
cluded in the meta-analysis were cross-sectional, and no more
than one measurement was carried out per study participant.
Previous meta-analyses
Two previous reviews were found to contain information regard-
ing the potential association between respondent burden and
t hits for searches performed in PubMed and EMBASE.
Initial hits Relevant
hits
16/98/38/111/8/110 0/1/1/1/0/0
4 0
0 0
118/645/119 0/0/0
391/451/42/233 2/4/0/0
203/484/146/128 8/0/0/0
187/341/17 0/0/0
188/149/380 0/0/0
3/1/11 0/0/0
3/21/0 0/0/0
17/0/0 0/0/0
5/22/5 0/0/0
22/41/4 0/0/0
14/54/41 4/0/0
n/a 11
4861 32van
den
dge*
rms.questionnaire length [23,24]. A systematic review of randomized,
Table 2 – Studies investigating the effect of questionnaire length on response rates.
Study Setting and design Topic Questionnaires shorter and longer Pages
shorter
Pages
longer
Received/sent
(RR %), shorter
questionnaire
Received/sent
(RR %), longer
questionnaire
Beebe et al., 2010 [35] Unaffiliated, randomized
postal survey
Functional gastrointestinal
disorders
Two versions of the Talley Bowel
Disease Questionnaire
2 4 169/379 (44.6) 194/401 (48.4)
Chlan, 2004 [11] Affiliated, nonrandomized
crossover
Anxiety VAS-A Anxiety and Spielberger State
Anxiety Inventory
1* 20* 200/200 (100) 192/200 (96)
Coast et al., 2006 [19] Affiliated, randomized
postal survey
Patient satisfaction with
care
Ad hoc without and with more
scenarios to consider
16* 36* 103/121 (85.1) 99/119 (83.2)
Cunningham et al., 1999 [20] Affiliated, randomized
postal survey
Alcohol Brief graduated frequency measure
and Timeline Followback
30* 365* 25/49 (51) 10/45 (22)
de Marco et al., 1999 [31] Affiliated, randomized
postal survey
Asthma Ad hoc without and with questions
of costs
1 2 64/142 (45) 53/140 (38)
Dirmaier et al., 2007 [34] Affiliated, randomized
postal survey
Psychiatry Ad hoc without and with
standardized psychiatric outcome
measures
13 23 1069/1948 (54.9) 960/1877 (51.1)
Dorman et al., 1997 [26] Affiliated, randomized
postal survey
Quality of life EuroQol and SF-36 4 8 905/1125 (75) 849/1128 (80)
Eaker et al., 1998 [27] Unaffiliated, randomized
postal survey
Medical history and risk
factors
Ad hoc 11 15 511/1000 (51.1.) 464/1000 (46.4)
Hoffman et al., 1998 [29] Affiliated, randomized
postal survey
Personal and family
medical history
Ad hoc 4 16 167/452 (37) 340/1029 (33)
Iglesias and Torgerson, 2000 [12] Affiliated, randomized
postal survey
Osteoporosis risk Ad hoc without and with EuroQol 4 5 131/278 (47) 134/278 (48)
Jacoby, 1990 [13] Affiliated and unaffiliated
patients, randomized
postal survey
Patient satisfaction with
care
Ad hoc 8 16 678/1000 (67.8) 684/1000 (68.4)
Jenkinson et al., 2003 [10] Affiliated, randomized
postal survey
Patient satisfaction with
care
Two versions of the Picker Patient
Experience
4 12 396/721 (67.7) 362/724 (63.7)
Kalantar and Talley, 1999 [36] Unaffiliated, randomized
postal survey
Gastrointestinal Ad hoc 1 7 166/220 (75.6) 150/220 (68.2)
Kaplan and Cole, 1970 [21] Unaffiliated, random
postal survey
Reproductive history Ad hoc 1* 5* 162/219 (73.9) 167/217 (76.9)
Kelly et al., 2010 [37] Unaffiliated, randomized
postal survey
Cancer Ad hoc 10 16 368/573 (64.2) 340/577 (58.9)
Lund and Gram, 1998 [14] Unaffiliated, randomized
postal survey
Women’s health Ad hoc 2 4 1294/2000 (64.7) 1185/2000 (59.2)
Mond et al., 2004 [15] Unaffiliated, randomized
postal survey
Health and well-being Ad hoc 8 14 194/401 (48.4) 230/401 (57.4)
Murawski and Carroll, 1996 [28] Affiliated, randomized
postal survey
Health status Duke Questionnaire and SF-36 1 5 132/200 (66) 131/200 (66)
Nagata et al., 1995 [16] Unaffiliated, randomized
postal survey
Medical history and risk
factors
Ad hoc 1 2 50/100 (50) 157/300 (52.3)
Ronckers et al., 2004 [32] Unaffiliated, randomized
postal survey
Nasopharyngeal radium
irradiation
Ad hoc 8 12 77/100 (77) 67/100 (67)
Salisbury et al., 2005 [22] Affiliated, randomized
postal survey
Patient satisfaction with
care
The Short Questionnaire for Out-of-
Hours Care and McKinley’s
Questionnaire for Out-of-Hours
Care
7* 36* 342/748 (45.7) 234/558 (41.9)
(continued on next page)
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1104 V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 1 1 0 1 – 1 1 0 8controlled trials undertaken to identify approaches that increase
response rates of postal surveys concluded that a response was
more likelywhen comparatively shorter questionnaireswere used
(OR 1.86; 95% CI 1.55–2.24) [23,24]. In this meta-analysis, question-
naires were dichotomized into shorter and longer on the basis of
the individual study authors’ definitions. As pointed out by others
[25], many of the trials included were outdated and on topics un-
related to health care, for example, marketing surveys. Conse-
quently, these findings have little clinical applicability.When only
published reports on a health-related subject cited in the review
were included, longer questionnaires were found to result in de-
creased response rates in 4 of 11 studies [12,26–28]. In the remain-
ing seven studies, there was no evidence of increased burden as
measured by response rate [13,14,16–18,21,29]. It should be noted
that not all of these studies compared different versions of the
same questionnaire, and some compared different questionnaires
altogether (e.g., SF-36 vs. EuroQol (EQ-5D) [26]). Ten of these stud-
ies were eligible for inclusion in thismeta-analysis. This literature
review included observational studies and was not restricted to
randomized studies.
The potential relationship between response rate and number
of items included in a questionnaire was investigated in another
review [24]. The number of items was stated in 125 of the studies
included and ranged from 1 to 361 (mean 28.1; SD 51). According to
authors, the correlation between the number of items and total
response ratewasweak (r 0.29). The authors concluded that high
response rates may be achieved even with longer questionnaires
(e.g., 15–20 pages). Evidence of the potential relationship between
response rate and questionnaire length not included in the re-
views cited previously [23,24] is presented.
Studies reporting a significant association between burden
and length
The relationship between attrition rate and questionnaire length
was examined in a postal survey of clinical patients [20]. Partici-
pants were randomly assigned to receive either a shorter (brief
graduated frequency measure) (n  49) or a longer (Timeline Fol-
lowback [TLFB]) (n  46) questionnaire assessing alcohol con-
umption. The response rate for the TLFB was 22% (10/45) com-
ared with 51% (25/49) for the relatively shorter questionnaire
2  6.5, df  1, P  0.01). No differences in demographic charac-
eristics were found for the participants receiving either question-
aire. The authors concluded that shorter questionnaires may be
referable to longer ones in postal surveys.
Chlan [11] compared response burden indirectly by adminis-
ering two anxiety instruments, the 20-item Spielberger State
nxiety Inventory (SAI) and a visual analog scale for anxiety (VAS-
), to all patients (n  200) receiving mechanical ventilator sup-
ort. A VAS consists of one single itemwhere level of agreement to
statement is indicated bymaking amark along a continuous line
etween two end points. Because all patients completed the
AS-A and eight did not complete the SAI, the authors concluded
hat the VAS-A was less burdensome than the SAI for patients
eceiving mechanical ventilator support.
Studies not reporting a significant association between
burden and length
A study conducted by Victor [30] investigated the feasibility of
administering questionnaires by mail to elderly patients upon
hospital discharge. Patients (n  300) were randomized to re-
ceive a questionnaire of either 4 or 12 pages in length on the
subject of disability and health status. Response rates among
survivors were comparable between the groups; 87% (117/135)
completed the shorter questionnaire, whereas 86% (118/138) re-
turned the longer one. Similar data quality was reported for
both groups.
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1105V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 1 1 0 1 – 1 1 0 8The influence of length of a questionnaire on the topic of
asthma on response rate was assessed in a pilot study [31]. Two
random samples of healthy respondents received either a one-
page (n 150) or a two-page (n 150) questionnaire. The response
rate for the two-page questionnairewas 7% lower than that for the
one-page version (38% vs. 45%). The difference was not statisti-
cally significant (95% CI 1% to 15%).
An epidemiological study pilot-tested (n  200) the effect of
uestionnaire length on response rate before selecting a question-
aire for distribution to a larger study cohort [32]. Although the
esults were not statistically significant (P  0.12; 95% CI for the
difference in proportion 2% to 22%), the response rate increased
from 67% to 77% when an eight-page questionnaire was adminis-
tered compared to one of 12 pages in length.
Subar et al. [33] administered two food frequency question-
naires by mail to a control group (n  900) in a cancer screening
trial. The authors reported no differenceswith respect to response
rate and data quality when comparing data for those who were
randomized to receive either the 16-page Prostate, Lung, Colorec-
tal, and Food Frequency Questionnaire (PLO FFQ) or the 36-page
Diet History Questionnaire (DHQ) (81.6% vs. 81.9%). Also, 58%
found the DHQ to be very easy to complete, whereas the corre-
sponding figure for the PLO FFQ was 50%. The authors reported
that themean proportion of missing or uninterpretable responses
did not differ by questionnaire type.
A study by Jenkinson and colleagues [10] compared two ver-
sions of various lengths of the Picker Patient Experience (PPE)
questionnaire. The study included patients recently discharged
from hospital (n  1445) who were randomized to receive either a
12- or a 4-page version of the PPE questionnaire. The authors
found no difference in response rate; 63.7% returned the longer
questionnaire, whereas 67.7% returned the shorter one. Also, the
data quality and psychometric properties of the PPE did not differ
between the two arms of the trial.
An epidemiological study by Mond et al. [15] on the effect of
questionnaire length and response rate concluded that little is
gained by decreasing questionnaire length. The overall response
rate was significantly higher for participants (n  401) who had
been mailed a 14-page questionnaire (57.4%) compared to those
(n 401) who had received an eight-page version, which excluded
some of the domains found in the longer versions (48.4%) (OR 1.44;
95% CI 1.09–1.9; P  0.01).
Salisbury et al. [22] compared the newly developed seven-item
Short Questionnaire for Out-of-Hours Care with a previously vali-
dated, longer 36-item questionnaire. Questionnaires were mailed
to patients (n  1906) contacting an out-of-hours general practi-
tioner cooperative. The authors found no significant difference
between the overall response rates obtained from the short or long
questionnaires (45.7% vs. 41.9%; P  0.17). More patients in the
short questionnaire group, however, completed all items (43.0%
vs. 36.4%; P  0.01).
In another study that sought to identify differences in comple-
tion rates in relation to questionnaire length, 36- and 16-item ver-
sions of a questionnaire were mailed to affiliated patients on the
subject of access to dermatology secondary-care services [19]. The
authors reported that 53% of the sample (n  240) agreed to par-
ticipate and that the response rate for the longer questionnaire
was 83.2% compared to 85.1% for the comparatively shorter ques-
tionnaire (difference, 1.9%; 95% CI 7.3 to 11.2; P  0.68). The au-
thors also reported that more patients completed all items in the
shorter questionnaire, but found this to be attributable to differ-
ences in items rather than length per se.
Dirmaier et al. [34] investigated whether abridging a longer
uestionnaire would increase response rates in a postal follow-up
urvey 1 year after inpatient psychotherapeutic treatment. Pa-
ients (n  3825) received either a prepaid monetary incentive or
one, and a 13- or 23-page questionnaire. Although a monetaryincentive increased the response rate by 7.3% (95% CI 2.6–11.9),
receiving the relatively shorter questionnaire resulted in anonsignif-
icant difference in response rate of 3.7% (95%CI 0.9–8.3, P 0.11); the
horter questionnaire was returned by 51.1% of the patients and the
onger oneby54.9%.Theauthors reportedno significant associations
etween questionnaire length and themean number ofmissing val-
es when adjusting for age, sex, and diagnosis.
A recent postal survey sought to investigate response burden
nd data quality indirectly by comparing response rates [35]. A
ohort of 780 patients was randomized to receive either a two- or
four-page long version of theTalley BowelDiseaseQuestionnaire
TBDQ). There were no significant differences (P  0.29) in re-
ponse rates between those who had received the long (194/401,
8.4%) and those who had received the short (169/379, 44.6%) ver-
ion of the TBDQ. Furthermore, the study did not report any dif-
erences between the questionnaires with respect to partial re-
ponses or time to submit the questionnaire.
Another epidemiological study evaluated the effects of lottery
ncentive and questionnaire length on response rates when used
n isolation or combined [36]. A random sample (n  440) of indi-
iduals was by chance assigned to be given or not given an instant
ottery ticket and a seven- or one-page questionnaire. The distri-
ution of the variable conditions, length, and lottery incentivewas
qual across groups. The final response rates were highest among
hose completing the shortest questionnaire (75.6% vs. 68.2%; P 
.08) but not significantly so. The possibility of receiving a com-
leted questionnaire without any follow-up reminders was signif-
cantly associated with the lottery incentive (P 0.03) but not with
he length of the questionnaire.
Patients with prostate or colon cancer (n 1200) were ran-
omly selected from a cancer registry to receive either a 10- or a
6-page questionnaire [37]. The response rate of the patients re-
eiving the comparatively shorter questionnaire was 64.2%, and
or the longer questionnaire, it was 58.9% (OR 0.79; P 0.06). It was
oncluded that the length of the questionnaire did not affect the
esponse rate significantly, even though there was a trend. No
ifferences between the two questionnaires were found regarding
ata quality.
Studies including patient input
Hassan and Weymuller [38] tested which instrument was pre-
erred by patients with head and neck cancer (n  75). Patients
ere administered the nine-item disease-specific University of
ashington-Quality of Life (UW-QOL) head and neck question-
aire and the 136-item generic Sickness Impact Profile (SIP). The
uthors reported that 97% of patients favored the shorter UW-QOL
ver the SIP when asked an open-ended question regarding pref-
rence. It should be noted, however, that the instruments used for
omparison differed markedly in terms of content.
In another study [39] that included patient (n  114) input,
patients with multiple sclerosis (MS) were asked to tick off which
of three questionnaires—EQ-5D (five items), SF-36 (36 items), or
Multiple Sclerosis Quality of Life-54 (MSQOL-54) (a combination of
SF-36 and 18 MS-specific questions)—that they found to summa-
rize most accurately their quality of life. Two percent preferred
EQ-5D, 5% preferred SF-36, 17% preferred the markedly longer
MSQOL-54, and the remaining 76% preferred a combination of se-
lected items from the three. About 90% of patients found all three
instruments acceptable and easy to respond to.
Nilsson et al. [40] studied patient satisfaction (n 463) with the
SF-36 and EQ-5D and patients’ perspectives regarding health out-
come assessment within a routine health-care context. Patients
completed the SF-36 and the EQ-5D before and after ordinary in-
terventions. An evaluation form was also used to capture respon-
dent satisfaction, where response alternatives for the cognitive
response process ranged from “very easy” to “very hard” and pa-
tient-perceived content validity ranged from “very good” to “very
1106 V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 1 1 0 1 – 1 1 0 8bad.” Furthermore, patients’ preference for either instrument for
use in routine health care was evaluated (response options were
yes, no, or don’t know), and an open-ended question gave patients
the opportunity to expand their answers further. Seventy percent
of patients found the SF-36 comprehensible, whereas 75% re-
ported the EQ-5D to be comprehensible (P 0.005). Corresponding
numbers concerning the instruments’ degree of easiness to re-
spond to were 54% for the SF-36 and 60% for the EQ-5D, respec-
tively (P  0.001). Patients considered both questionnaires to be
equally applicable (68%). Even though the SF-36 consists of 36
items compared to 5 for the EQ-5D, it was preferred for routine
assessment by 25% of patients, whereas only 8% favored the rela-
tively shorter questionnaire (P  0.001). The authors concluded
that questionnaire length and ease of response were not crucial
factors influencing the choice between the SF-36 and EQ-5D.
Results
Meta-analysis of the association between questionnaire
length and response rate
In themeta-analysis, a general association between response rate
and questionnaire length (P  0.0001) was found; response rates
were somewhat lower for longer questionnaires. The Cochran-
Mantel-Haenszel estimate of the common OR over all strata was
1.14 and the 95% CI was 1.08–1.21. The P value for the Breslow-Day
test was 0.03, indicating heterogeneity in ORs by study. Hence, the
validity of the estimate of the common OR can be questioned, and
this value should be interpretedwith caution. Consequently, there
is no clear indication that the difference in overall response rates
is attributable to the differences in length between the question-
naires. Data on the numbers of pages used for shorter and longer
questionnaires are not included in the analysis but are illustrated
Fig. 1 – The proportion bibof responders according to the
length of the questionnaire within each study included in
the statistical analysis (n = 20). Each line represents one
study and connects the proportion of responders for the
short questionnaire and the long questionnaire within
each study. The width of the line is proportional to the
number of subjects in each study.in Figure 1.Discussion
Respondent burden, as measured by response rate, is frequently
used as an incentive to develop brief instruments and abbreviate
existing ones and is mentioned as a general obstacle in clinical
practice to the administration of PROs. The aim of this literature
review was to compile and evaluate systematically evidence of a
potential relationship between questionnaire length and respon-
dent burden. In total, 25 studies were found that examined the
relationship indirectly by means of response rates; of these, only
six reported significantly reduced response rates when longer
questionnaires were administered. In our meta-analysis, there
was a greater chance of response when patients were presented
with a comparatively shorter questionnaire. Results, however, of
the test of homogeneity indicated that factors other than length
may have been at least as important per se. We found only three
studies examining respondent burden more directly.
Measuring burden
Some studies have used time to complete a questionnaire as a
measure of burden, for example, that of Haley et al. [41]. Because
relying on time alone assumes that completing a questionnaire is
burdensome by itself and that the passage of more time equals
more burden without testing the presumption against any mea-
sure, these studies were not included in the literature review.
Time per se provides no information as to whether the time spent
on the questionnaire was burdensome.
Comparatively shorter time to complete a questionnaire could
even reflect a reduced effort to engage in the questions asked.
Consequently, longer time to complete a questionnaire could im-
ply that the respondent was more motivated and hence less bur-
dened. Most studies investigating respondent burden have done
so by hypothesizing that higher response rates imply reduced bur-
den. Although this hypothesis is plausible, it is at best an assump-
tion because response rates do not provide any information as to
why a questionnaire is not returned. Studies involving some type
of patient input would help to clarify the reasons for not returning
a questionnaire. Our systematic search found only three studies
that touched on the concept of respondent burden by directly ask-
ing the patients which questionnaire they preferred and why.
Measurement context
Edwards et al. [23] previously reviewed factors relating to response
rates of postal surveys, including published and unpublished arti-
cles spanning decades from various fields ranging from medicine
to marketing. It was reported that a response was more likely
when short questionnaires were used. Because the result of the
test for homogeneity of the OR, however, was highly significant
(P 0.00001), other factors are likely to have influenced the results.
Also, there is reason to believe that a respondent’s motivation to
complete a marketing survey would differ from a scenario in
which the outcome of the assessment is believed to be important
for evaluation of their health status. In our study, the findings are
presented based on populations with and without clinical affilia-
tion, and similar motivational differences may apply to the study
of Edwards et al. Typically, epidemiological studies rely on regis-
tries with patients whomay have no affiliation to the organization
conducting the research. However, the subject of an epidemiolog-
ical survey may be of greater relevance to the respondent than
that ofmostmarketing studies. Not only are studies with a clinical
foundation based on a topic of potentially crucial relevance to
affiliated respondents, but the patients involved may also believe
that returning the questionnaire may affect their treatment out-
come. A concern that has frequently been raised is that response
burden may be greater in severely ill patients, older individuals,
children, and some demographic groups [4]. This concern may,
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lation of interest because several studies have failed to find any
consistent relationship between compliance and population char-
acteristics [42–46]. For example, 51 of 68 (75%) terminally ill pa-
tients with a life expectancy of less than 2 months reported no
burden associated with completing an extensive battery of ques-
tionnaires [47].
Psychometric and statistical issues
A general concern with the shortening of instruments is validity
and reliability. Instruments relying on one single question have, in
general, very poor psychometric properties. For example, reduc-
tion in the number of items may result in a limited scope, which
could lead to an instrument being insensitive to changes. A more
specific issue is the number of studies needed to detect a signifi-
cant difference in response rate between shorter and longer ques-
tionnaires. In this study, 6 of 25 studies reported lower response
rates for participants who received a longer questionnaire. How-
ever, a marginal yet statistically significant difference was found
when data for all 24,326 participants were included in an analysis
stratified by study. When missing data are the only measure of
respondent burden, the kind of missing data is important. Are the
datamissing at random, completely at random, or not at random?
Reduced response rate and missing data will lead to a smaller
sample size that, in turn, will reduce the probability of meeting
study objectives. Only if the data are missing completely at ran-
domcan this bemitigated by sample size calculations before start-
ing a study. Of more concern is the potential bias caused by miss-
ing data that cannot be consideredmissing completely at random.
Eleven of the 25 studies that used response rates as a measure of
burden included information regarding missing data and partial
responses. Asmethods for reporting partially missing data varied,
no comparative analyses were performed. Overall, seven studies
reported that there were no differences in data quality, one re-
ported better data quality for the comparatively longer question-
naire and three for the shorter questionnaire. Finally, it should be
noted that in a number of the cited studies, the reported response
rates were so low that the generalizability of the findings was
compromised; for example, Cunningham et al. [20] reported that
only 22% of the patients returned the longer questionnaire. There
is some evidence indicating that mode of delivery influences re-
sponse rates (i.e., home interviewing and personal delivery is pref-
erable to postal delivery [15,48]), and it has been proposed that the
method by which a questionnaire is distributed is of greater im-
portance than its length [15].
Comparisons of length or content?
An inherent problem with comparisons of questionnaire length
is the relativity of the object of study. In the studies discussed,
the number of pages compared was the most commonly re-
portedmeasure. Themeaning of “short” varied from 1 item to 16
pages, whereas “long” could be anything from 2 to 36 pages. Not
only were there differences between studies, but also within
studies. Although the increment expressed as a percentage for a
study comparing one with two pages is equal to that of one
comparing 16 with 36 pages, the additional time spent complet-
ing the questionnaire is clearly greater in the latter case. Thus,
the number of pages may not be the most ideal measure of the
effort needed to complete a questionnaire. Furthermore, the
items comprising an instrument may differ vastly in complex-
ity, for example, in terms of number of response options. The
response burden is likely to be more pronounced when a re-
spondent completes a shorter questionnaire with complex re-
sponse choices compared to a longer questionnaire with more
straightforward response alternatives. Another complication is
that in most cases, it is impossible to separate out the effect ofincreased length from the content that is being added or re-
moved when comparing two versions of the same question-
naire. This notion is substantiated by the significant result of
the homogeneity test. It should also be noted that not all the
studies reviewed compared different versions of the same ques-
tionnaire—some included comparisons of different question-
naires. For instance, Hassan and Weymuller [38] compared the
generic SIP to the disease-specific and shorter UW-QOL. Ques-
tionnaires are often abridged when they are perceived to be too
lengthy. If an instrument is successfully abbreviated from a
content perspective, the reason that response rates would be
higher for the shorter alternative is as likely to be related to
content as to length—the least relevant items may have been
the ones discarded. However, abridged and designated short
instruments are rarely developed on the basis of patient input,
but rather are guided by the outcome of a psychometric valida-
tion (e.g., factor analysis). Because length and content are diffi-
cult to separate out, the subject of quantity is indiscernible from
that of quality. Thus, content validity, the degree to which the
instrument measures the intended idea, is of equal importance
to the length of the questionnaire per se. Evidence of content
validity may be obtained from qualitative studies supporting
the appropriateness of selection of domains and subordinate
items of an instrument in relation to intention, target popula-
tion, and utility [1]. Furthermore, the content validity of an in-
strument is dependent on the population studied, disease, and
treatment. None of the reviewed studies that used response
rates as outcome to study influence of length on response bur-
den investigated whether items, domains, and scoring were
found to be comprehensive and relevant from a patient’s point
of view. Evidence of other types of validity (e.g., construct va-
lidity) will not diminish the need for content validation because
the instrument needs to demonstrate that it measures all rele-
vant aspects [1]. Three studies were identified that relied on
patient input regarding questionnaire length. In two of these,
patients were simply asked which instrument they preferred
[38,39]. Findings from these studies indicate that patients would
prefer a disease-specific instrument over a generic one, even
when the instrument is more voluminous. A similar conclusion
could be derived from the study conducted by Nilsson et al. [40],
which both asked for the preference of instrument and included
more fine-grained response alternatives for the recording of
preference and comprehensibility. These studies exemplify
how patient input may be obtained when deciding which in-
strument to use. Shifting focus from the length of the question-
naire to the content is likely to affect response rates positively;
if the questions are deemed relevant, patients are more likely to
be motivated to respond.
Concern about respondent burden has mostly focused on re-
ducing the number of items in a questionnaire, but respondent
burden may be more profound when the patient is asked to com-
plete multiple questionnaires [49,50]. For example, the burden
may be greaterwhen the questionnaires included in a study reflect
similar concepts (e.g., when clinical trials involve multiple ques-
tionnaires being administered on numerous occasions covering
similar or identical concepts for research purposes). Rather than
including similar shorter questionnaires, reducing the overlap of
content between instruments may be more beneficial with regard
to reduction of response burden. Also, given increased regulatory
demands on questionnaires used in clinical trials [1], which may
result in increased sampling density, there is a risk that repeated
assessments may strain the patient. However, knowledge regard-
ing the association of response burdenwith repeated assessments
is limited, and future studies should investigate the potential
relationship between sampling density and degree of response
burden.
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Given the weak support for an association between questionnaire
length and response burden, decisions on the choice of instru-
ment are best based on the quality of the content from the pa-
tient’s point of view rather than the length per se.
Source of financial support: This study was financed by Astra-
Zeneca R&D, Mölndal, Sweden.
R E F E R E N C E S
[1] Guidance for Industry Patient-Reported OutcomeMeasures: Use in
Medical Product Development to Support Labeling Claims. US
Department of Health and Human Services Food and Drug
Administration; Center for Drug Evaluation and Research (CDER); Center
for Biologics Evaluation and Research (CBER); Center for Devices and
Radiological Health (CDRH), December 2009. Available from: www.fda.
gov/downloads/ Drugs/Guidance ComplianceRegulatoryInformation/
Guidances/UCM193282.pdf. [Accessed February 1, 2011].
[2] Diehr P, Chen L, Patrick D, et al. Reliability, effect size, and
responsiveness of health status measures in the design of randomized
and cluster-randomized trials. Contemp Clin Trials 2005;26:45–58.
[3] Snyder CF, Watson ME, Jackson JD, et al. Patient-reported outcome
instrument selection: designing a measurement strategy. Value Health
2007;10(Suppl. 2): S76–85.
[4] Stone A, Shiffman S, Atienza A, et al. The Science of Real-time Data
Capture. New York: Oxford University Press, 2007.
[5] Ware J, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey:
construction of scales and preliminary tests of reliability and validity.
Med Care 1996;34:220–33.
[6] Mark TL, Johnson G, Fortner B, et al. The benefits and challenges of
using computer-assisted symptom assessments in oncology clinics:
results of a qualitative assessment. Technol Cancer Res Treat 2008;7:
401–6.
[7] Bize R, Plotnikoff RC. The relationship between a short measure of
health status and physical activity in a workplace population. Psychol
Health Med 2009;14:53–61.
[8] Agresi A. Categorical Data Analysis. Hoboken, NJ: John Wiley & Sons,
Inc., 1990.
[9] Breslow NE, Day N L. The Design and Analysis of Cohort Studies. New
York: Oxford University Press, 1994.
10] Jenkinson C, Coulter A, Reeves R, et al. Properties of the Picker Patient
Experience questionnaire in a randomized controlled trial of long
versus short form survey instruments. J Public Health Med 2003;25:
197–201.
11] Chlan LL. Relationship between two anxiety instruments in patients
receiving mechanical ventilatory support. J Adv Nurs 2004;48:493–9.
12] Iglesias C, Torgerson D. Does length of questionnaire matter? A
randomised trial of response rates to a mailed questionnaire. J Health
Serv Res Policy 2000;5:219–21.
13] Jacoby A. Possible factors affecting response to postal questionnaires:
findings from a study of general practitioner services. J Public Health
Med 1990;12:131–5.
14] Lund E, Gram IT. Response rate according to title and length of
questionnaire. Scand J Soc Med 1998;26:154–60.
15] Mond JM, Rodgers B, Hay PJ, et al. Mode of delivery, but not
questionnaire length, affected response in an epidemiological study of
eating-disordered behavior. J Clin Epidemiol 2004;57:1167–71.
16] Nagata C, Hara S, Shimizu H. Factors affecting response to mail
questionnaire: research topics, questionnaire length, and non-
response bias. J Epidemiol 1995:815.
17] Spry VM, Hovell MF, Sallis JG, et al. Recruiting survey respondents to
mailed surveys: controlled trials of incentives and prompts. Am J
Epidemiol 1989;130:166–72.
18] Vogel P, Skjostad K, Eriksen L. Influencing return rate by mail of
alcoholics= questionnaires at follow-up by varying lottery procedures
and questionnaire lengths. Eur J Psychiatry 1992;6:213–22.
19] Coast J, Flynn TN, Salisbury C, et al. Maximising responses to discrete
choice experiments: a randomised trial. Appl Health Econ Health
Policy 2006;5:249–60.
20] Cunningham JA, Ansara D, Wild TC, et al. What is the price of
perfection? The hidden costs of using detailed assessment
instruments to measure alcohol consumption. J Stud Alcohol 1999;60:
756–8.21] Kaplan S, Cole P. Factors affecting response to postal questionnaires.
Br J Prev Soc Med 1970;24:245–7.[22] Salisbury C, Burgess A, Lattimer V, et al. Developing a standard short
questionnaire for the assessment of patient satisfaction with out-of-
hours primary care. Fam Pract 2005;22:560–9.
[23] Edwards P, Roberts I, Clarke M, et al. Increasing response rates to
postal questionnaires: systematic review. BMJ 2002;324:1183.
[24] Sitzia J, Wood N. Response rate in patient satisfaction research: an
analysis of 210 published studies. Int J Qual Health Care 1998;10:311–7.
[25] Smeeth L, Fletcher AE. Improving the response rates to
questionnaires. BMJ 2002;324:1168–9.
[26] Dorman PJ, Slattery J, Farrell B, et al. A randomised comparison of the
EuroQol and Short Form-36 after stroke. United Kingdom collaborators
in the International Stroke Trial. BMJ 1997;315:461.
[27] Eaker S, Bergström R, Bergström A, et al. Response rate to mailed
epidemiologic questionnaires: a population-based randomized trial of
variations in design and mailing routines. Am J Epidemiol 1998;147:
74–82.
[28] Murawski M, Carroll N. Direct mail performance of selected health
related quality of life scales. J Pharmacoepidemiol 1996;5:17–38.
[29] Hoffman SC, Burke AE, Helzlsouer KJ, et al. Controlled trial of the
effect of length, incentives, and follow-up techniques on response to a
mailed questionnaire. Am J Epidemiol 1998;148:1007–11.
[30] Victor CR. Some methodological aspects of using postal
questionnaires with the elderly. Arch Gerontol Geriatr 1988;7:163–72.
[31] de Marco R, Zanolin ME, Accordini S, et al. A new questionnaire for
the repeat of the first stage of the European Community Respiratory
Health Survey: a pilot study. Eur Respir J 1999;14:1044–8.
[32] Ronckers C, Land C, Hayes R, et al. Factors impacting questionnaire
response in a Dutch retrospective cohort study. Ann Epidemiol 2004;
14:66–72.
[33] Subar AF, Ziegler RG, Thompson FE, et al. Is shorter always better?
Relative importance of questionnaire length and cognitive ease on
response rates and data quality for two dietary questionnaires. Am J
Epidemiol 2001;153:404–9.
[34] Dirmaier J, Harfst T, Koch U, et al. Incentives increased return rates
but did not influence partial nonresponse or treatment outcome in a
randomized trial. J Clin Epidemiol 2007;60:1263–70.
[35] Beebe TJ, Rey E, Ziegenfuss JY, et al. Shortening a survey and using
alternative forms of prenotification: impact on response rate and
quality. BMC Med Res Methodol 2010;10:50.
[36] Kalantar JS, Talley NJ. The effects of lottery incentive and length of
questionnaire on health survey response rates: a randomized study.
J Clin Epidemiol 1999;52:1117–22.
[37] Kelly BJ, Fraze TK, Hornik RC. Response rates to a mailed survey of a
representative sample of cancer patients randomly drawn from the
Pennsylvania Cancer Registry: a randomized trial of incentive and
length effects. BMC Med Res Methodol 2010;10:65.
[38] Hassan SJ, Weymuller EA. Assessment of quality of life in head and
neck cancer patients. Head Neck 1993;15:485–96.
[39] Moore F, Wolfson C, Alexandrov L, et al. Do general and multiple
sclerosis-specific quality of life instruments differ? Can J Neurol Sci
2004;31:64–71.
[40] Nilsson E, Wenemark M, Bendtsen P, et al. Respondent satisfaction
regarding SF-36 and EQ-5D, and patients’ perspectives concerning
health outcome assessment within routine health care. Qual Life Res
2007;16:1647–54.
[41] Haley SM, Gandek B, Siebens H, et al. Computerized adaptive testing
for follow-up after discharge from inpatient rehabilitation: II.
Participation outcomes. Arch Phys Med Rehabil 2008; 89:275–83.
[42] Chmelik F, Doughty A. Objective measurements of compliance in
asthma treatment. Ann Allergy 1994;73:527–32.
[43] Jonasson G, Carlsen KH, Sodal A, et al. Patient compliance in a clinical
trial with inhaled budesonide in children with mild asthma. Eur
Respir J 1999;14:150–4.
[44] Mazze RS, Shamoon H, Pasmantier R, et al. Reliability of blood
glucose monitoring by patients with diabetes mellitus. Am J Med
1984;77:211–7.
[45] Milgrom H, Bender B, Ackerson L, et al. Noncompliance and
treatment failure in children with asthma. J Allergy Clin Immunol
1996;98:1051–7.
[46] Simmons Z, Bremer BA, Robbins RA, et al. Quality of life in ALS
depends on factors other than strength and physical function.
Neurology 2000;55:388–92.
[47] Pessin H, Galietta M, Nelson CJ, et al. Burden and benefit of
psychosocial research at the end of life. J Palliat Med 2008;11:627–32.
[48] Picavet HS. National health surveys by mail or home interview: effects
on response. J Epidemiol Community Health 2001;55:408–13.
[49] Turner RR, Quittner AL, Parasuraman BM, et al. Patient-reported
outcomes: instrument development and selection issues. Value
Health 2007;109(Suppl. 20):S86–93.[50] Vickers AJ. How to improve accrual to clinical trials of symptom
control 2: design issues. J Soc Integr Oncol 2007;5:61–4.
